Papain-like proteases of staphylococcus aureus

Advances in Experimental Medicine and Biology

Volumn 712, Issue , 2011, Pages 1-14

  Kantyka, Tomasz ^a   Shaw, Lindsey N ^b   Potempa, Jan ^a,c  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; ENZYME PRECURSOR; PAPAIN; STAPHOPAIN A; STAPHOPAIN B; STAPHOSTATIN A; STAPHOSTATIN B; UNCLASSIFIED DRUG; BACTERIAL PROTEIN;

ARTICLE; BACTERIAL GENE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC CONSERVATION; GENETIC ORGANIZATION; HUMAN; HYDROPHOBICITY; MOLECULAR INTERACTION; NONHUMAN; OPERON; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUORUM SENSING; SEQUENCE HOMOLOGY; STAPHOPAIN A GENE; STAPHOPAIN B GENE; STAPHOSTATIN A GENE; STAPHOSTATIN B GENE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; PATHOGENICITY; REVIEW; VIRULENCE;

BACTERIAL PROTEINS; ENZYME ACTIVATION; PAPAIN; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 80053333971     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8414-2_1     Document Type: Article

References (55)

1. Foster TJ. The Staphylococcus aureus "superbug". J Clin Invest 2004; 114(12):1693-1696
2. Ferry T, Perpoint T, Vandenesch F et al. Virulence determinants in Staphylococcus aureus and theirinvolvement in clinical syndromes. Curr Infect Dis Rep 2005; 7(6):420-428
3. Abdelnour A, Arvidson S, Bremell T et al. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 1993; 61(9):3879-3885
4. Cheung AL, Eberhardt KJ, Chung E et al. Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest 1994; 94(5):1815-1822
5. Vuong C, Gotz F, Otto M. Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis. Infect Immun 2000; 68(3):1048-1053
6. Kavanaugh JS, Thoendel M, Horswill AR. A role for type I signal peptidase in Staphylococcus aureus quorum sensing. Mol Microbiol 2007; 65(3):780-798
7. Queck SY, Jameson-Lee M, Villaruz AE et al. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol Cell 2008; 32(1):150-158
8. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 2003; 48(6):1429-1449
9. McGavin MJ, Zahradka C, Rice K et al. Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease. Infect Immun 1997; 65(7):2621-2628
10. Karlsson A, Saravia-Otten P, Tegmark K et al. Decreased amounts of cell wall-associated protein A and fibronectin-binding proteins in Staphylococcus aureus sarA mutants due to up-regulation of extracellular proteases. Infect Immun 2001; 69(8):4742-4748
11. McAleese FM, Walsh EJ, Sieprawska M et al. Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease. J Biol Chem 2001; 276(32):29969-29978
12. Cheung AL, Ying P. Regulation of alpha- and beta-hemolysins by the sar locus of Staphylococcus aureus. J Bacteriol 1994; 176(3):580-585
13. Chien Y, Manna AC, Projan SJ et al. SarA, a global regulator of virulence determinants in Staphylococcus aureus, binds to a conserved motif essential for sar-dependent gene regulation. J Biol Chem 1999; 274(52):37169-37176
14. Rechtin TM, Gillaspy AF, Schumacher MA et al. Characterization of the SarA virulence gene regulator of Staphylococcus aureus. Mol Microbiol 1999; 33(2):307-316
15. Novick RP, Ross HF, Projan SJ et al. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J 1993; 12(10):3967-3975
16. Chan PF, Foster SJ. Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J Bacteriol 1998; 180(23):6232-6241
17. Arvidson S. Extracellular Enzymes. In: Fischetti VA, Novick RP, ferretti JJ, Potrnoy DA, Rood JIe, editors. Gram-positive pathogens. Washington D.C.: American Society for Microbiology, 2000: 379-385
18. Ziebandt AK, Weber H, Rudolph J et al. Extracellular proteins of Staphylococcus aureus and the role of SarA and sigma B. Proteomics 2001; 1(4):480-493
19. Massimi I, Park E, Rice K et al. Identification of a novel maturation mechanism and restricted substrate specificity for the SspB cysteine protease of Staphylococcus aureus. J Biol Chem 2002; 277(44):41770-41777
20. Drapeau GR, Boily Y, Houmard J. Purification and properties ofan extracellular protease of Staphylococcus aureus. J Biol Chem 1972; 247(20):6720-6726
21. Arvidson S, Holme T, Lindholm B. Studies on extracellular proteolytic enzymes from Staphylococcus aureus. I. Purification and characterization of one neutral and one alkaline protease. Biochim Biophys Acta 1973; 302(1):135-148
22. Arvidson S. Studies on extracellular proteolytic enzymes from Staphylococcus aureus. II. Isolation and characterization of an EDTA-sensitive protease. Biochim Biophys Acta 1973; 302(1):149-157
23. Reed SB, Wesson CA, Liou LE et al. Molecular characterization of a novel Staphylococcus aureus serine protease operon. Infect Immun 2001; 69(3):1521-1527
24. Rice K, Peralta R, Bast D et al. Description ofstaphylococcus serine protease (ssp) operon in Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine protease. Infect Immun 2001; 69(1):159-169
25. Potempa J, Watorek W, Travis J. The inactivation of human plasma alpha 1-proteinase inhibitor by proteinases from Staphylococcus aureus. J Biol Chem 1986; 261(30):14330-14334
26. Potempa J, Fedak D, Dubin A et al. Proteolytic inactivation of alpha-1-anti-chymotrypsin. Sites of cleavage and generation of chemotactic activity. J Biol Chem 1991; 266(32):21482-21487
27. Prokesova L, Potuznikova B, Potempa J et al. Cleavage of human immunoglobulins by proteinase from Staphylococcus aureus. Adv Exp Med Biol 1995; 371A:613-616
28. Potempa J, Banbula A, Travis J. Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000; 24:153-192
29. Imamura T, Tanase S, Szmyd G et al. Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus. J Exp Med 2005; 201(10):1669-1676
30. Smagur J, Guzik K, Bzowska M et al. Staphylococcal cysteine protease staphopain B (SspB) induces rapid engulfment of human neutrophils and monocytes by macrophages. Biol Chem 2009; 390(4):361-371
31. Maeda H, Yamamoto T. Pathogenic mechanisms induced by microbial proteases in microbial infections. Biol Chem Hoppe Seyler 1996; 377(4):217-226
32. Lindsay JA, Foster SJ. Interactive regulatory pathways control virulence determinant production and stability in response to environmental conditions in Staphylococcus aureus. Mol Gen Genet 1999; 262(2):323-331
33. Dunman PM, Murphy E, Haney S et al. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol 2001; 183(24):7341-7353
34. Shaw L, Golonka E, Potempa J et al. The role and regulation of the extracellular proteases of Staphylococcus aureus. Microbiology 2004; 150(Pt 1):217-228
35. Tegmark K, Morfeldt E, Arvidson S. Regulation of agr-dependent virulence genes in Staphylococcus aureus by RNAIII from coagulase-negative staphylococci. J Bacteriol 1998; 180(12):3181-3186
36. Drapeau GR. Role of metalloprotease in activation of the precursor of staphylococcal protease. J Bacteriol 1978; 136(2):607-613
37. Filipek R, Rzychon M, Oleksy A et al. The Staphostatin-staphopain complex: a forward binding inhibitor in complex with its target cysteine protease. J Biol Chem 2003; 278(42):40959-40966
38. Rzychon M, Sabat A, Kosowska K et al. Staphostatins: an expanding new group of proteinase inhibitors with a unique specificity for the regulation of staphopains, Staphylococcus spp. cysteine proteinases. Mol Microbiol 2003; 49(4):1051-1066
39. Karlsson A, Arvidson S. Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease repressor sarA. Infect Immun 2002; 70(8):4239-4246
40. Dubin G, Krajewski M, Popowicz G et al. A novel class of cysteine protease inhibitors: solution structure of staphostatin A from Staphylococcus aureus. Biochemistry 2003; 42(46):13449-13456
41. Rzychon M, Filipek R, Sabat A et al. Staphostatins resemble lipocalins, not cystatins in fold. Protein Sci 2003; 12(10):2252-2256
42. Nickerson NN, Joag V, McGavin MJ. Rapid autocatalytic activation of the M4 metalloprotease aureolysin is controlled by a conserved N-terminal fungalysin-thermolysin-propeptide domain. Mol Microbiol 2008; 69(6):1530-1543
43. Marie-Claire C, Roques BP, Beaumont A. Intramolecular processing of prothermolysin. J Biol Chem 1998; 273(10):5697-5701
44. Hoffman B, Schomburg D, Hecht HJ. Crystal structure of a thiol proteinase from Staphylococcus aureus V8 in the E-64 inhibitor complex. Acta Crystallographica 1993;(49):102
45. Nickerson N, Ip J, Passos DT et al. Comparison of Staphopain A (ScpA) and B (SspB) precursor activation mechanisms reveals unique secretion kinetics of proSspB (Staphopain B) and a different interaction with its cognate Staphostatin, SspC. Mol Microbiol 2010; 75(1):161-177
46. Coulter SN, Schwan WR, Ng EY et al. Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol Microbiol 1998; 30(2):393-404
47. Potempa J, Pike RN. Bacterial peptidases. Contrib Microbiol 2005; 12:132-180
48. Potempa J, Dubin A, Korzus G et al. Degradation of elastin by a cysteine proteinase from Staphylococcus aureus. J Biol Chem 1988; 263(6):2664-2667
49. Dubin G. Extracellular proteases of Staphylococcus spp. Biol Chem 2002; 383(7-8):1075-1086
50. Wegrzynowicz Z, Heczko PB, Drapeau GR et al. Prothrombin activation by a metalloprotease from Staphylococcus aureus. J Clin Microbiol 1980; 12(2):138-139
51. Jones RC, Deck J, Edmondson RD et al. Relative quantitative comparisons of the extracellular protein profiles of Staphylococcus aureus UAMS-1 and its sarA, agr and sarA agr regulatory mutants using one-dimensional polyacrylamide gel electrophoresis and nanocapillary liquid chromatography coupled with tandem mass spectrometry. J Bacteriol 2008; 190(15):5265-5278
52. Wladyka B, Puzia K, Dubin A. Efficient co-expression of a recombinant staphopain A and its inhibitor staphostatin A in Escherichia coli. Biochem J 2005; 385(Pt 1):181-187
53. Copeland A, Lucas S, Lapidus A et al. Complete sequence of chromosome of Staphylococcus aureus subsp.aureus JH9. 2007
54. Filipek R, Potempa J, Bochtler M. A comparison of staphostatin B with standard mechanism serine protease inhibitors. J Biol Chem 2005; 280(15):14669-14674
55. Dubin G, Wladyka B, Stec-Niemczyk J et al. The staphostatin family of cysteine protease inhibitors in the genus Staphylococcus as an example of parallel evolution of protease and inhibitor specificity. Biol Chem 2007; 388(2):227-235